Oncology - Now Enrolling
Adults with Diffuse Large B-Cell Lymphoma (DLBCL) May Qualify for a Clinical Trial
Join a local research study evaluating the safety and efficacy of an investigational treatment combined with chemotherapy for treating Diffuse Large B-Cell Lymphoma (DLBCL).
​
If you meet the following criteria, you may be eligible:
-
Age: 18 years or older
-
Diagnosis: Previously untreated DLBCL (CD20+)
-
International Prognostic Index (IPI): ≥2
-
ECOG Performance Status: ≤2
-
Measurable disease with at least one nodal lesion or extranodal lesion
​
This study aims to compare the effects of the investigational treatment combined with chemotherapy in participants with untreated DLBCL.
​
Qualified Participants May Receive:
-
No-cost study-related care and medications
-
Regular assessments and monitoring throughout the study
-
Compensation for study-related time and travel
​
Metabolic - Now Enrolling
Adults with Obesity or Overweight May Qualify for a Clinical Trial​
Join a local research study investigating an investigational treatment for weight management.
If you meet the following criteria, you may be eligible:​
-
Ages 18-75
-
BMI ≥ 30.0 kg/m² or BMI ≥ 27.0 kg/m² with weight-related conditions like hypertension, sleep apnea, or cardiovascular disease
​
This study aims to evaluate the investigational treatment in comparison to a placebo and an FDA-approved treatment for obesity.
​
Qualified Participants May Receive:
-
No-cost study-related care and medications
-
Compensation for study-related time and travel
​
Explore ClinVax
ClinVax Clinical Trials Solutions
1331 N Grand Parkway
Suite 111
Katy, TX 77493
​
T: 1 833 254 6829
F: 1 281 533 8188
Privacy Policy
©Copyright 2025 ClinVax | All RIghts Reserved.